Menopause
Conference Coverage
Early estrogen loss increases cardiovascular risk in women
Clinicians should especially be aware of functional hypothalamic amenorrhea as a condition that could increase women’s risk of cardiovascular...
Conference Coverage
Nonhormonal drug fezolinetant found safe for hot flashes in yearlong study
Although additional safety studies await fezolinetant before it heads to the FDA for approval, it appears to be on its way to offering women an...
Conference Coverage
Menopause symptoms negatively affect women’s work
With 13% of women reporting a major impact on their work from menopause symptoms, the study still may underestimate the effects of this life...
Latest News
Hormone changes: The star of every stage in women’s sleep
There’s still a lot of work to be done in terms of better defining the characteristics specific to each sleep disorder and how they relate to each...
Latest News
Early or delayed menopause and irregular periods tied to new-onset atrial fibrillation
Findings highlight the significance of considering the reproductive history of women while developing tailored screening and prevention strategies...
Guidelines
New ovulatory disorder classifications from FIGO replace 50-year-old system
Once an ovulatory disorder has been diagnosed, four basic categories provide a framework for classification.
From the Journals
Early menopause linked with increased risk of heart problems
A study of more than 1.4 million women revealed that the younger the age at menopause, the higher the risk of heart failure and atrial...
Latest News
Does cannabis help with menopause symptoms?
Women with symptoms of menopause are turning to cannabis for help, researchers have found, despite a lack of evidence that the drug works for...
Guidelines
NAMS affirms value of hormone therapy for menopausal women
Recent research supports individualized care to maximize benefits and minimize risks.
Latest News
Routine weight counseling urged for women at midlife
“Midlife women gain weight at an average of approximately 1.5 pounds per year, which increases their risk for transitioning from normal or...
Latest News
Hormone therapy didn’t increase recurrence or mortality in women treated for breast cancer
Recurrence was increased with vaginal hormone therapy among those taking aromatase inhibitors.